Cargando…
Epidermal Growth Factor Receptor in Pancreatic Cancer
Pancreatic cancer is the fourth leading cause of cancer related death. The difficulty in detecting pancreatic cancer at an early stage, aggressiveness and the lack of effective therapy all contribute to the high mortality. Epidermal growth factor receptor (EGFR) is a transmembrane glycoprotein, whic...
Autores principales: | Oliveira-Cunha, Melissa, Newman, William G., Siriwardena, Ajith K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757375/ https://www.ncbi.nlm.nih.gov/pubmed/24212772 http://dx.doi.org/10.3390/cancers3021513 |
Ejemplares similares
-
Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy
por: Faller, Bryan A, et al.
Publicado: (2009) -
Epidermal Growth Factor Receptor and Its Role in Pancreatic Cancer Treatment Mediated by Nanoparticles
por: Grapa, Cristiana Maria, et al.
Publicado: (2019) -
The epidermal growth factor receptor family in breast cancer
por: Koutras, Angelos K, et al.
Publicado: (2008) -
The Role of Epidermal Growth Factor Receptor Mutations and Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in the Treatment of Lung Cancer
por: Chang, Shih-Chieh, et al.
Publicado: (2011) -
Targeting the Epidermal Growth Factor Receptor in Addition to Chemotherapy in Patients with Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Chiramel, Jaseela, et al.
Publicado: (2017)